Loading...

APC anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_APC_091809
C57BL/6 bone marrow cells stained with 1A8 APC
  • 1A8_APC_091809
    C57BL/6 bone marrow cells stained with 1A8 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
127613 25 µg 71€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127614 100 µg 252€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  2. Patras KA, et al. 2019. J Innate Immun. :1. PubMed
  3. Yu‐Han Chang et al. 2017. Immunity. 47(5):943-958 . PubMed
  4. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  5. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  6. Stein K, et al. 2016. J Leukoc Biol. 99: 231 - 239. PubMed
  7. Christian D, et al. 2014. Infect Immun . 82:4056. PubMed
  8. Sharma A, et al. 2014. J Infect Dis. . PubMed
  9. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  10. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  11. Wenzek C, et al. 2022. iScience. 25:105540. PubMed
  12. Ding Z, et al. 2021. Int J Mol Sci. 22:. PubMed
  13. Weiss M, et al. 2015. Proc Natl Acad Sci U S A. 112: 11001-11006. PubMed
  14. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  15. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  16. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  17. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  18. Poli V, et al. 2021. iScience. 24:103256. PubMed
  19. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  20. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  21. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  22. Han J, et al. 2022. FEBS J. 289:417. PubMed
  23. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  24. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  25. Patnode M, et al. 2014. J Exp Med. 211:1281. PubMed
  26. Liao H, et al. 2015. Rheumatology. 54: 1317 - 1326. PubMed
  27. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  28. Thompson ER, et al. 2020. Am J Transplant. . PubMed
  29. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  30. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  31. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  32. Meng L, et al. 2021. Front Oncol. 11:691705. PubMed
  33. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  34. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  35. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  36. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  37. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  38. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  39. Yao ME, et al. 2022. Evid Based Complement Alternat Med. 2022:7784148. PubMed
  40. Pawaria S, et al. 2020. Arthritis Rheumatol. 72:359. PubMed
  41. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  42. Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
  43. Ma Y, et al. 2016. Cardiovasc Res. 110: 51 - 61. PubMed
  44. Karmakar M, et al. 2016. Nat Commun. 7:10555. PubMed
  45. Chu C, et al. 2016. Dis Model Mech. 9: 473-481. PubMed
  46. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  47. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  48. Parlet CP, et al. 2019. Cell Rep. 27:187. PubMed
  49. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  50. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  51. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  52. Michael BD, et al. 2020. Cell Reports. 32(11):108150. PubMed
  53. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  54. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  55. Goldman E, et al. 2021. Cells. 10:. PubMed
  56. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  57. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  58. Cui C, et al. 2021. Cell. 184(12):3163-3177.e21. PubMed
  59. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  60. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  61. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  62. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  63. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  64. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  65. Gottfried-Blackmore A, et al. 2009. Proc Natl Acad Sci U S A. 106:20918. PubMed
  66. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  67. Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
  68. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  69. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  70. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  71. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  72. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  73. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  74. Zhou Q, et al. 2014. J Immunol. 193:496. PubMed
  75. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  76. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  77. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  78. Wang SS et al. 2018. Cell chemical biology. 25(12):1519-1532 . PubMed
  79. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  80. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  81. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  82. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  83. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  84. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  85. Price P, et al. 2015. J Immunol. 194:1164. PubMed
  86. Albarrán-Juárez J, et al. 2016. Atherosclerosis. 251:445-53. PubMed
  87. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  88. Fraccarollo D, et al. 2021. eLife. 0.416666666666667. PubMed
  89. Li H, et al. 2019. Front Immunol. 2.205555556. PubMed
  90. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  91. Cho K, et al. 2021. iScience. 24:103117. PubMed
  92. Gurusamy M, et al. 2021. Nat Commun. 12:6798. PubMed
  93. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  94. Machácek T, et al. 2022. PLoS Pathog. 18:e1010302. PubMed
  95. Xiao Y, et al. 2022. Dis Markers. 2022:1380560. PubMed
  96. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23: . PubMed
  97. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  98. Steichen A, et al. 2015. PLoS One. 10:123573. PubMed
  99. Cohen M, et al. 2014. EMBO J. 33:2906. PubMed
  100. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  101. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  102. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  103. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  104. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  105. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  106. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  107. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  108. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  109. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  110. Wang SS, et al. 2021. Cell Chemical Biology. 28(5):699-710.e5. PubMed
  111. Peñaloza HF, et al. 2018. Biochem Biophys Rep. 13:12. PubMed
  112. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  113. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  114. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  115. Namiguchi K, et al. 2022. Front Cardiovasc Med. 8:761591. PubMed
  116. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  117. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  118. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  119. Wingrove E et al. 2019. Cell reports. 27(4):1277-1292 . PubMed
  120. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  121. Ohno-Urabe S, et al. 2018. J Am Heart Assoc. 7:e007389. PubMed
  122. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  123. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  124. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  125. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  126. Resende M, et al. 2019. J Immunol. 203:2451. PubMed
  127. Salvagno C, et al. 2019. Nat Cell Biol. 1.229861111. PubMed
  128. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  129. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  130. Chua Y, et al. 2016. J Immunol. 197: 3771 - 3781. PubMed
  131. Ulrich V, et al. 2016. EMBO Mol Med. 8: 643 - 653. PubMed
  132. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  133. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  134. Kwon MY, et al. 2021. J Leukoc Biol. 110:711. PubMed
  135. Skokowa J, et al. 2022. Nat Commun. 13:2948. PubMed
  136. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  137. Kamei A, et al. 2012. J Infect Dis. 207:39. PubMed
  138. Gardner P, et al. 2015. Am J Pathol. 185:1324. PubMed
  139. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  140. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  141. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  142. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  143. Molgora M, et al. 2020. Cell. 182:886. PubMed
  144. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  145. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  146. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  147. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  148. Gautam S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 319:L661. PubMed
  149. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  150. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  151. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  152. Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
  153. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  154. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  155. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  156. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  157. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  158. Cardoso M, et al. 2015. Infect Immun . 83: 3534-3544. PubMed
  159. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  160. Zhang J et al. 2019. Cell Rep. 27(9):2679-2689 . PubMed
  161. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  162. Oertli M, et al. 2011. J Immunol. 187:3578. PubMed
  163. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
  164. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  165. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  166. Young K, et al. 2021. Cell Stem Cell. . PubMed
  167. Cardoso F, et al. 2015. PLoS One. 10: 0131904. PubMed
  168. Devi S, et al. 2013. J Exp Med. 210:2321. PubMed
  169. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  170. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  171. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  172. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  173. Wang S, et al. 2022. Blood. 140:171. PubMed
  174. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
RRID
AB_1877163 (BioLegend Cat. No. 127613)
AB_2227348 (BioLegend Cat. No. 127614)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01-06-2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account